Unexplained lumps and what you should do about them

Unexplained lumps and what you should do regarding them Sarcomas, rare types of cancer, can often first appear as seemingly harmless lumps.

Key points

• Siddharth Turkar is a consultant in medical oncology at Apollo Hospitals Navi Mumbai.
• Sarcomas are rare, accounting for regarding 1% of cancers in adults and roughly 15% of cancers in children.
• Most soft-tissue lumps are benign, so neither patients nor clinicians naturally assume that a new lump is a cancer.
• The term 'unplanned excision' is applied when a soft-tissue sarcoma is removed without appropriate preoperative imaging, histological confirmation or an oncological surgical plan.
• For a suspicious extremity soft-tissue mass, MRI is usually the preferred local imaging test.

Most soft-tissue lumps are benign, so neither patients nor clinicians naturally assume that a new lump is a cancer. Yet sarcoma can present with little more than a gradually enlarging swelling. Photo Credit: Wikipedia Commons.

Plenty of soft-tissue sarcomas. It are rare types of cancers that form in fat, muscles and blood vessels, initially look like ordinary lumps. When a suspicious mass of this sort is removed without appropriate imaging, tissue diagnosis or oncological planning, the opportunity for the simplest and best-planned first operation may already have been lost, nevertheless.

Sarcomas in India, are therefore not only a difficulty of late diagnosis. Some are additionally operated on before a diagnosis is properly established. A first operation performed without sarcoma-specific planning can create subsequent treatment more extensive, even when the disease remains potentially curable.

In practice, a retrospective analysis in AIIMS, Delhi of 157 patients with localised extremity synovial sarcoma discovered that more than 70% of patients reached a specialist centre only after an unplanned surgery or a recurrence.

Sarcomas are rare, accounting for regarding 1% of cancers in adults and roughly 15% of cancers in children. Their rarity is part of the challenge. Most soft-tissue lumps are benign, so neither patients nor clinicians naturally assume that a new lump is a cancer. Yet sarcoma can present with little more than a gradually enlarging swelling.

In practice, a soft-tissue sarcoma may appear well circumscribed, but that apparent boundary can be deceptive. Some tumours develop a surrounding pseudocapsule, and microscopic tumour cells may extend into or beyond it. If a sarcoma is removed without appropriate oncological margins, residual tumour may remain in the surgical bed. The operation that follows may then need to remove the previous scar and potentially contaminated tissues and, in some patients, may require more complex reconstruction.

Meanwhile, the term 'unplanned excision' is applied when a soft-tissue sarcoma is removed without appropriate preoperative imaging, histological confirmation or an oncological surgical plan. Evidence does not backing the idea that such an operation automatically destroys the chance of cure. Nevertheless, it can rise the risk of local recurrence and frequently creates the need for a second, wider operation to clear the tumour bed.

Notably, the AIIMS synovial sarcoma series illustrates both sides of this difficulty. Despite more than 70% of patients arriving after an unplanned operation or recurrence, limb salvage was still achieved in 64%. This is an significant message for patients: an earlier inappropriate operation is serious, but it does not mean that amputation or treatment failure is inevitable. Prompt referral to a sarcoma team can still preserve meaningful treatment options. Signs that should trigger a referral.

Not every lump needs an MRI or a biopsy. But certain features should create a clinician stop before simply removing it. A soft-tissue mass that is enlarging, is regarding 5 centimetres or larger, lies deep to the fascia, has suspicious or indeterminate imaging features, or has returned after a previous removal deserves specialist assessment. When sarcoma is suspected, current imaging guidance recommends referral to a sarcoma or tumour reference centre before biopsy or surgery.

For a suspicious extremity soft-tissue mass, MRI is usually the preferred local imaging test. If malignancy remains a concern, a carefully planned image-guided core-needle biopsy is generally the standard way to establish the diagnosis before definitive surgery. Small, superficial lesions may sometimes be managed differently. It is why the decision should be based on the whole clinical and imaging picture, rather than size alone.

Pain is not a reliable safety signal. Soft-tissue sarcoma can present as a painless lump, and the absence of pain should not reassure someone if a mass is enlarging or has other concerning features. The practical message is simple: a persistent or growing unexplained lump deserves an assessment, not an assumption.

Sarcoma is not one disease but a heterogeneous family of cancers with plenty of distinct subtypes. Diagnosis and treatment may require input from musculoskeletal radiology, specialist pathology, surgical oncology or orthopaedic oncology, radiation oncology and medical oncology. This is why major guidelines emphasise assessment in, or in close collaboration with, a specialist sarcoma centre when the diagnosis is suspected.

Three beliefs are particularly harmful: that a painless lump must be harmless, that biopsy itself is more dangerous than obtaining a diagnosis, and that sarcoma automatically means amputation. None is a safe assumption. Modern sarcoma care is built around diagnosis before definitive treatment and, for extremity tumours, limb-preserving treatment is feasible for numerous patients.

Better referral pathways between primary care, general surgical services and specialist centres can prevent avoidable unplanned excisions. The goal is not to send every small lump to a cancer centre; it is to recognise the few features that should trigger imaging, biopsy planning and specialist input before the first incision.

Meanwhile, the first operation on a suspected sarcoma can shape what becomes necessary afterwards. For an unexplained lump with concerning features, diagnosis and planning should come before excision. Sometimes the most significant cancer treatment decision is the one produced before anyone enters the operating theatre.

(Dr. Siddharth Turkar is a consultant in medical oncology at Apollo Hospitals Navi Mumbai. [email protected]).

For now, unexplained lumps and what you should do about them remains the part of the story worth watching, and further updates are likely as more details are confirmed.